These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 9232337
1. Urinary estrogen metabolites and breast cancer: a case-control study. Kabat GC, Chang CJ, Sparano JA, Sepkovie DW, Hu XP, Khalil A, Rosenblatt R, Bradlow HL. Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):505-9. PubMed ID: 9232337 [Abstract] [Full Text] [Related]
2. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer. Alvarez-Vasquez RB, Axelrod D, Frenkel K, Newman MC, Sepkovic DW, Bradlow HL, Zumoff B. Horm Metab Res; 2003 Jun; 35(6):358-61. PubMed ID: 12920658 [Abstract] [Full Text] [Related]
3. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Krajcik RA, Borofsky ND, Massardo S, Orentreich N. Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045 [Abstract] [Full Text] [Related]
4. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study. Wellejus A, Olsen A, Tjonneland A, Thomsen BL, Overvad K, Loft S. Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2137-42. PubMed ID: 16172222 [Abstract] [Full Text] [Related]
6. Estrogen metabolites and the risk of breast cancer in older women. Cauley JA, Zmuda JM, Danielson ME, Ljung BM, Bauer DC, Cummings SR, Kuller LH. Epidemiology; 2003 Nov; 14(6):740-4. PubMed ID: 14569192 [Abstract] [Full Text] [Related]
7. Urinary phytoestrogens and postmenopausal breast cancer risk. den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH. Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):223-8. PubMed ID: 11303591 [Abstract] [Full Text] [Related]
8. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. Nichols HB, Trentham-Dietz A, Love RR, Hampton JM, Hoang Anh PT, Allred DC, Mohsin SK, Newcomb PA. Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474 [Abstract] [Full Text] [Related]
9. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, Folsom AR. Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):89-94. PubMed ID: 11219777 [Abstract] [Full Text] [Related]
10. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE. J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882 [Abstract] [Full Text] [Related]
11. Serum fatty acids and risk of breast cancer in a nested case-control study of the New York University Women's Health Study. Saadatian-Elahi M, Toniolo P, Ferrari P, Goudable J, Akhmedkhanov A, Zeleniuch-Jacquotte A, Riboli E. Cancer Epidemiol Biomarkers Prev; 2002 Nov 20; 11(11):1353-60. PubMed ID: 12433711 [Abstract] [Full Text] [Related]
12. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women. Miyoshi Y, Tanji Y, Taguchi T, Tamaki Y, Noguchi S. Clin Cancer Res; 2003 Jun 20; 9(6):2229-33. PubMed ID: 12796390 [Abstract] [Full Text] [Related]
13. Reproductive factors and breast cancer risk among older women. Shantakumar S, Terry MB, Teitelbaum SL, Britton JA, Millikan RC, Moorman PG, Neugut AI, Gammon MD. Breast Cancer Res Treat; 2007 May 20; 102(3):365-74. PubMed ID: 17033925 [Abstract] [Full Text] [Related]
14. Association of serum adiponectin levels with breast cancer risk. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S. Clin Cancer Res; 2003 Nov 15; 9(15):5699-704. PubMed ID: 14654554 [Abstract] [Full Text] [Related]
15. Early-life physical activity and postmenopausal breast cancer: effect of body size and weight change. Shoff SM, Newcomb PA, Trentham-Dietz A, Remington PL, Mittendorf R, Greenberg ER, Willett WC. Cancer Epidemiol Biomarkers Prev; 2000 Jun 15; 9(6):591-5. PubMed ID: 10868694 [Abstract] [Full Text] [Related]
16. Fasting glucose is a risk factor for breast cancer: a prospective study. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F. Cancer Epidemiol Biomarkers Prev; 2002 Nov 15; 11(11):1361-8. PubMed ID: 12433712 [Abstract] [Full Text] [Related]
17. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L. Cancer Epidemiol Biomarkers Prev; 2000 Jul 15; 9(7):681-7. PubMed ID: 10919738 [Abstract] [Full Text] [Related]
18. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Helzlsouer KJ, Alberg AJ, Huang HY, Hoffman SC, Strickland PT, Brock JW, Burse VW, Needham LL, Bell DA, Lavigne JA, Yager JD, Comstock GW. Cancer Epidemiol Biomarkers Prev; 1999 Jun 15; 8(6):525-32. PubMed ID: 10385143 [Abstract] [Full Text] [Related]
19. Energy balance and breast cancer risk: a prospective cohort study. Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE. Breast Cancer Res Treat; 2006 May 15; 97(1):97-106. PubMed ID: 16319973 [Abstract] [Full Text] [Related]
20. Association of paternal age at birth and the risk of breast cancer in offspring: a case control study. Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Yoo KY, Kang D. BMC Cancer; 2005 Oct 31; 5():143. PubMed ID: 16259637 [Abstract] [Full Text] [Related] Page: [Next] [New Search]